LumiraDx Limited (LMDXF)
OTCMKTS: LMDXF · Delayed Price · USD
0.0122
0.00 (0.00%)
Jul 2, 2024, 12:00 AM EDT - Market closed
LumiraDx Market Cap
LumiraDx has a market cap or net worth of $221.35 million as of July 3, 2024. Its market cap has decreased by -20.97% in one year.
Market Cap
221.35M
Enterprise Value
598.77M
1-Year Change
-20.97%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since January 27, 2021, LumiraDx's market cap has increased from $127.00M to $221.35M, an increase of 74.29%. That is a compound annual growth rate of 20.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2024 | 5.10M | -74.63% |
| Dec 29, 2023 | 20.10M | -92.66% |
| Dec 30, 2022 | 274.00M | -87.64% |
| Dec 31, 2021 | 2.22B | 1,645.67% |
| Jan 27, 2021 | 127.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 870.77B |
| Novo Nordisk | 643.36B |
| UnitedHealth Group | 461.37B |
| Johnson & Johnson | 352.82B |
| Merck & Co. | 325.90B |
| AbbVie | 301.92B |
| AstraZeneca | 242.24B |
| Novartis AG | 209.27B |